Circadian rhythms in blood pressure, heart rate, hormones, and on polysomnographic parameters in severe obstructive sleep apnea syndrome patients: Effect of continuous positive airway pressure

Blood Pressure Monitoring

Volumn 21, Issue 3, 2016, Pages 136-143

  Lemmer, Björn ^a   Scholtze, Joachim ^a   Schmitt, Judith ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

activity; ambulatory blood pressure monitoring; continuous positive airway pressure; heart rate; norepinephrine and melatonin; obstructive sleep apnea syndrome; polysomnography; rhythm in blood pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MELATONIN; NORADRENALIN;

APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BIOLOGICAL RHYTHM; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; DIASTOLIC BLOOD PRESSURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MOTOR ACTIVITY; NORADRENALIN BLOOD LEVEL; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RADIOIMMUNOASSAY; REM SLEEP; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLOW WAVE SLEEP; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; BLOOD; CLINICAL TRIAL; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART RATE; HUMANS; MALE; MELATONIN; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84950140901     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000173     Document Type: Article

References (64)

1. Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-Term effects nasal continuous positive airway pressure on daytime sleepiness, mood, and traffic accidents in patients with obstructive sleep apnoea. Respir Med. 2000; 94: 87-90.
2. Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep. 2000; 23 (Suppl 4): S102-S108.
3. Moog R, Fietze I, Penzel T, Peter JH, Vogel M. Circadian reactions to nCPAP treatment. Chronobiol Int. 1998; 15: 265-273.
4. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones, and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16: 274-280.
5. Borgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Buchner N, et al. Obstructive sleep apnea, and blood pressure: interaction between the blood pressure-lowering effects of positive airway pressure therapy, and antihypertensive drugs. Am J Hypertens. 2004; 17 (Pt 1): 1081-1087.
6. Hermida RC, Zamarron C, Ayala DE, Calvo C. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit. 2004; 9: 193-202.
7. Calhoun DA, Harding SM. Sleep, and hypertension. Chest. 2010; 138: 434-443.
8. Sanner BM, Tepel M, Markmann A, Zidek W. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens. 2002; 15: 251-257.
9. Verin E, Similowski T, Series F. Effects of continuous positive airway pressure on upper airway inspiratory dynamics in awake patients with sleep-disordered breathing. J Physiol. 2003; 546 (Pt 1): 279-287.
10. Bilge AR, Yavuz V, Cetin N, Dalgic O, Kum G, Yilmaz H, et al. The effect of long-Term continuous positive airway pressure treatment on systolic, and diastolic function in patients with obstructive sleep apnoea syndrome: a five year observational study. Anadolu Kardiyol Derg. 2014; 14: 265-271.
11. Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol. 2007; 293: R1671-R1683.
12. Boyaci H, Gacar K, Baris SA, Basyigit I, Yildiz F. Positive airway pressure device compliance of the patients with obstructive sleep apnea syndrome. Adv Clin Exp Med. 2013; 22: 809-815.
13. Fletcher EC. Cardiovascular effects of continuous positive airway pressure in obstructive sleep apnea. Sleep. 2000; 23 (Suppl 4): S154-S157.
14. Iftikhar IH, Valentine CW, Bittencourt LR, Cohen DL, Fedson AC, Gislason T, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension, andobstructive sleep apnea: a metaanalysis. J Hypertens. 2014; 32: 2341-2350; discussion 50.
15. Douglas NJ, Engleman HM. Effects of CPAP on vigilance, and related functions in patients with the sleep apnea/hypopnea syndrome. Sleep. 2000; 23 (Suppl 4): S147-S149.
16. Dhillon S, Chung SA, Fargher T, Huterer N, Shapiro CM. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens. 2005; 18 (Pt 1): 594-600.
17. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea, and hypertension: a placebo-controlled trial. Chest. 2006; 129: 1459-1467.
18. Burioka N, Koyanagi S, Endo M, Takata M, Fukuoka Y, Miyata M, et al. Clock gene dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J. 2008; 32: 105-112.
19. Lee YJ, Jeong DU. Obstructive sleep apnea syndrome is associated with higher diastolic blood pressure in men but not in women. Am J Hypertens. 2014; 27: 325-330.
20. Gaines J, Vgontzas AN, Fernandez-Mendoza J, Kritikou I, Basta M, Bixler EO. Gender differences in the association of sleep apnea, and inflammation. Brain Behavior Immunity. 2015; 47: 211-217.
21. Kapsimalis F, Kryger MH. Gender, andobstructive sleep apnea syndrome, part 1; clinical features. Sleep. 2002; 25: 412-419.
22. Lemmer B, Nold G. Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension. Blood Press Monit. 2003; 8: 119-125.
23. Lemmer B. Chronobiology, and chronopharmacology of hypertension: importance of timing of dosing. In: White WB, editor. Blood pressure monitoring in cardiovascular medicine, and therapeutics. Totowa, NJ: Humana Press; 2007. pp. 410-435.
24. Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens. 2002; 15 (Pt 1): 111-118.
25. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999; 100: 2332-2335.
26. Selmanoui B, Touitou Y. Reproducibility of the circadian rhythms of serum cortisol, and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci. 2003; 14: 3339-3349.
27. Lemmer B, Nold G, Kern R. Jet lag at the Olympics: 24-hour blood pressure profile, and time zone transition. In: Holick MF, Jung EG, editors. Biologic effects of light 1998. Boston, London, Dordrecht: Kluwer Academic Publishers; 1999. pp. 447-454.
28. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014; 23: 3-16.
29. Johns MW A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14: 540-545.
30. Bloch KE, Schoch OD, Zhang JN, Russi EW. German version of the Epworth Sleepiness Scale. Respiration. 1999; 66: 440-447.
31. Rechtschaffen A, Kales A A manual of stand ardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles, CA: BIS/BRI, UCLA; 1968.
32. NN. EEG arousals: scoring rules, and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep. 1992; 15: 173-184.
33. Zuther P, Gorbey S, Lemmer B. Chronos-Fit revised version 1.06; 2009. Available at: http://wwwmauni-heidelbergde/inst/phar/lehre/chronohtml. [Accessed 2 October 2015].
34. Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998; 3: 17-25.
35. Middeke M, Lemmer B. Office hypertension: abnormal blood pressure regulation, and increased sympathetic activity compared with normotension. Blood Press Monit. 1996; 1: 403-407.
36. Ackermann H. BIAS. Biometrische Analyse von Stichproben. Darmstadt, Germany: Epsilon-Verlag; 2002.
37. Palatini P. Importance of heart rate in determining cardiovascular risk. In: White WB, editor. Blood pressure monitoring in cardiovascular medicine, and therapeutics. Totowa, NJ: Humana Press; 2001. pp. 159-170.
38. Lemmer B. The importance of biological rhythms in drug treatment of hypertension, and sex-dependent modifications. ChronoPhysiol Ther. 2012; 2: 9-18.
39. Lemmer B, Brühl T, Witte KPB, Köhler W, Toitou Y. Effedt of bright light on circadian patters of cyclic adenosine monophosphate, melatonin, and cortisol in healthy subjects. Eur J Endocrinol. 1994; 130: 472-477.
40. Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity, and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res. 2007; 30: 669-676.
41. Kario K. Obstructive sleep apnea syndrome, and hypertension: ambulatory blood pressure. Hypertens Res. 2009; 32: 428-432.
42. Tsioufis C, Kasiakogias A, Thomopoulos C, Manolis A, Stefanadis C. Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication, and chronotherapy. J Hypertens. 2010; 28: 875-882.
43. Okcay A, Somers VK, Caples SM. Obstructive sleep apnea, and hypertension. J Clin Hypertens (Greenwich). 2008; 10: 549-555.
44. Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K, et al. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens. 2015; 33: 393-400.
45. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Timedependent effect of isradipine on the nocturnal hypertension of chronic renal failure. Am J Hypertens. 1995; 8: 719-726.
46. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning, and evening dosing of nisoldipine ER on circadian blood pressure, and heart rate. Am J Hypertens. 1999; 12 (Part 1): 806-814.
47. Lemmer B, Luders S, Nold G, Schrader J, Manfredini R, Portaluppi F. Normalisation of non-dipping blood pressure profile by amlodipine after single morning or evening dosing. Am J Hypertens. 2002; 15 (Pt 2): 109.
48. Lemmer B. The importance of circadian rhythms on drug response in hypertension, and coronary heart disease - from mice, and man. Pharmacol Ther. 2006; 111: 629-651.
49. Noda A, Yasuma F, Okada T, Yokota M. Influence of movement arousal on circadian rhythm of blood pressure in obstructive sleep apnea syndrome. J Hypertens. 2000; 18: 539-544.
50. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea, and normal matched control subjects. Thorax. 2000; 55: 736-740.
51. Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping, and non-dipping blood pressure profile. Life Sci. 2005; 76: 1795-1803.
52. Touitou Y, Fevre M, Bogdan A, Reinberg A, De Prins J, Beck H, et al. Patterns of plasma melatonin with aging, and mental condition: stability of nyctohemeral rhytms, and differences in seasonal variation. Acta Endocrinol. 1984; 106: 145-151.
53. Hernandez C, Abreu J, Abreu P, Castro A, Jimenez A. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J. 2007; 30: 496-500.
54. Papaioannou I, Twigg GL, Kemp M, Roughton M, Hooper J, Morrell MJ, et al. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea. Sleep Med. 2012; 13: 167-171.
55. Hsing A, Meyer T, Niwa S, Quraishi S, Chu L. Measuring serum melatonin in epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2010; 19: 932-937.
56. Arendt J, Van Someren EJ, Appleton R, Skene DJ, Akerstedt T. Clinical update: melatonin, and sleep disorders. Clin Med. 2008; 8: 381-383.
57. Arendt J, Deacon S. Treatment of circadian rhythm disorders - melatonin. Chronobiol Int. 1997; 14: 185-204.
58. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P. The role of melatonin in acute myocardial infarction. Front Biosci (Land mark Ed). 2012; 17: 2433-2441.
59. Paul T, Lemmer B. Disturbance of circadian rhythms in analgosedated intensive care unit patients with, and without craniocerebral injury. Chronobiol Int. 2007; 24: 45-61.
60. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. Am Coll Cardiol. 2009; 29: 343-346.
61. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985; 313: 1315-1322.
62. Fournier S, Taffe P, Radovanovic D, Von Elm E, Morawiec B, Stauffer JC, et al. Myocardial infarct size, and mortality depend on the time of day: a large multicenter study. PLoS One. 2015; 10: e0119157.
63. Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, et al. Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am J Emerg Med. 2004; 22: 555-559.
64. Rodriguez-Roisin R, Anzueto A, Borbeau J, deGuia T, Hui D, Martinez F, et al.; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2011 revision. Available at: http://www.goldcopd.org/uploads/users/.files/GOLD-Report-2011-Feb21.pdf. [Accessed 28 October 2015].